RLMD
Relmada Therapeutics Inc
3.70$
-2.9%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 73.0% | 78.7% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 27.0% | 21.3% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | 104,895.2% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 114.5% | 878.8% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 178.7% | 899.0% | – | – | – | – | – | – | – | – | – | – | – | – | |
| -151.8% | -877.7% | – | – | – | – | – | – | – | – | – | – | – | – | |
| -151.8% | -877.7% | – | – | – | – | – | – | – | – | – | – | – | – | |
| -4.7% | -186,862.6% | – | – | – | – | – | – | – | – | – | – | – | – | |
| -151.8% | -877.7% | – | – | – | – | – | – | – | – | – | – | – | – | |
| -147.0% | -877.7% | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.